Abbott Molecular
Lead Partner
Abbott Molecular is an experienced global health care partner and a proven leader in
successful companion diagnostic development.
Abbott Molecular provides physicians with critical information based on the early detection
of pathogens and subtle changes in patients’ genes and chromosomes, allowing for earlier
diagnosis, selection of appropriate therapies and monitoring of disease progression. The
product portfolio includes instruments and reagents used to conduct sophisticated analysis
of patient DNA and RNA through Real-Time PCR, FISH and Sequencing Technologies.
One Partner. A Total Solution. www.abbottmolecular.com
.
QIAGEN Plenary Expertise Partner QIAGEN work with pharmaceutical partners to support development of targeted cancer therapies by providing molecular companion diagnostic assays for mutational profiling, gene signature and methylation analysis. QIAGEN have also developed novel diagnostics for monitoring immunomodulators. Read more...
Ventana Plenary Expertise Partner www.ventanamed.com
PrimeraDx Expertise Partner PrimeraDx is a molecular diagnostics company that has developed a game-changing clinical platform which combines PCR with capillary electrophoresis. The result of combining these two technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative, answers to the clinic. The company is pursuing a two-pronged strategy to sell the system to clinical labs and to collaborate with pharmaceutical companies to develop high-value companion diagnostic products. Users can easily design very complex multi-modal assays that test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes. PrimeraDx’s technology represents the next generation of quantitative PCR. www.primeradx.com
Almac Expertise Partners Almac partners with the biopharmaceutical industry to provide biomarker discovery and development solutions ranging from pre-clinical biomarker discovery, through to full companion diagnostic development, biomarker clinical trial management and clinical test delivery from our CLIA lab. www.almacgroup.com Read more...
Myriad RBM Expertise Partner Myriad RBM, Inc. is the world’s leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) technology platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. www.myriadrbm.com Read more...
MolecularMD Plenary Expertise Partner MolecularMD develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMD’s assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. www.molecularmd.com
Boston Healthcare Expertise Partners Boston Healthcare's unique approach, combining strategic consulting with a deep understanding of the patient and provider access, reimbursement, and health economic environment gives drug, device, diagnostics companies a real-world edge in assessing and capturing global market and business development opportunities. www.bostonhealthcare.com Read more...
PANGAEA Biotech Expertise Partner Based in Barcelona, Pangaea Biotech’s mission is to implement a global R&D strategy that results in the personalized treatment of cancer patients. www.pangaeabiotech.com Read more...
OrigGene Expertise Partner OriGene Technologies uses a high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Starting from our TrueClone cDNA collection, a searchable gene bank of over 38,000 full-length cDNAs, we have created over 7,000 full-length human proteins expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB project of 5,000 highly validated mouse monoclonal antibodies in a variety of applications. In 2012, OriGene launched the UltraMAB Antibody collection. UltraMAB Antibodies are ultra-specific or "mono-specific" antibodies validated against 10,000+ human antigens and designed for diagnostic and therapeutic applications. www.origene.com
Asuragen Technology Spotlight Partner Asuragen is a molecular diagnostic company focused on personalizing oncology treatment through the development of novel diagnostics. www.asuragen.com Read more...
ResearchDx Spotlight Partner ResearchDx is a Contract Diagnostics Organization (CDO) developing and delivering in vitro diagnostics/companion diagnostics for the Pharmaceutical and Diagnostics industries. They offer a full range of IVD development services from assay discovery, consulting, validation and testing, to protocol development, project management, site monitoring/management, sample procurement, FDA submissions, and GMP manufacturing. www.researchdx.com
Ipsos Healthcare Spotlight Partner Ipsos Healthcare, the leader in providing global patient audit data in Oncology, is launching a new syndicated product to complement its Global Oncology Monitor, further strengthening its Global Oncology Portfolio. This new study, the Oncology Molecular Diagnostics Monitor, aims to provide a comprehensive, multi-stakeholder view of the rapidly expanding cancer global MDx market. The Oncology Molecular Diagnostics Monitor is set to launch in Q2 2012, with first wave results available in Q3. Initial market coverage will include US and 5EU, with additional launches in Japan and APAC expected later this year. www.ipsos-mori.com
Cureline Featured Exhibitor Cureline is a global biomarker/diagnostic CRO specializing in human biospecimen procurement and processing. www.cureline.com Read more...
Thermo Scientific Expertise Partner Thermo Scientific is a global leader in allergy, asthma and autoimmunity diagnostics. Thermo Scientific now offers access to both its leading expertise and platforms, for you to develop R&D assays as well as clinical tests. Successfully co-developing a drug and diagnostic is fraught with major difficulties that are often preventing success of this companion diagnostics strategy. Thermo Scientific is your ideal partner in biopharmaceutical immune response monitoring. We are No. 1 in allergy testing with a 75% market share worldwide. With more than 40 years of R&D in immunology and assay development, plus extensive manufacturing capabilities, 3000 certified test laboratories and a complete supply chain, we support you all the way from R&D to post-market companion diagnostics. Working with Thermo Scientific reduces assay development times, ensures high performance and worldwide supply of final tests. www.thermoscientific.com
Definiens Expertise Partner Definiens is the leading provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. www.definiens.com Read more...